Latest filing published 28 Jun 2023 for Acrivon Therapeutics, Inc., €190.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -70.9%Entry US$12.53 · Close at T+365 US$3.65
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Chione Ltd: trading record in brief
Filings by Chione Ltd span 2 companies, the busiest being Karyopharm Therapeutics Inc. and Acrivon Therapeutics, Inc. Over a trading history stretching from 12 November 2013 to 26 June 2023, the count stands at 81 filings.
The open-market side counts 1 purchase for €4.8M alongside 76 sales for €68.4M. Taken together, the sales exceed the purchases by €63.6M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2023: no purchases and 5 sales on the market.
The latest filing, published on 28 June 2023, reports an open-market sale of €190 in Acrivon Therapeutics, Inc. The last insider purchase was made public on 21 November 2022, 1,449 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Chione Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16 shares@ US$12.930.0% of flowCommon StockSEC:0001213900-23-052442:0
- 2,056 shares@ US$12.140.5% of flowCommon StockSEC:0001213900-23-050160:0
- 2,000 shares@ US$12.340.5% of flowCommon StockSEC:0001213900-23-049014:0
- 3,000 shares@ US$12.300.7% of flowCommon StockSEC:0001213900-23-049014:1
- 893 shares@ US$12.130.2% of flowCommon StockSEC:0001213900-23-049014:2
- 3,445,940 sharesCommon StockSEC:0001213900-22-074313:1
- 10,657 sharesCommon StockSEC:0001213900-22-074313:2
- 400,000 shares@ US$12.5099.1% of flowCommon StockSEC:0001213900-22-074313:0Canonical exit: 15 Feb 2023 (T+90)
- 149,624 shares@ US$4.13788.0% of flowCOMMON STOCKSEC:0001213900-19-003551:0
- 558,243 shares@ US$4.506732.4% of flowCOMMON STOCKSEC:0001213900-19-003242:2
- 800,000 shares@ US$4.993651.7% of flowCOMMON STOCKSEC:0001213900-19-003242:0
- 123,400 shares@ US$5.00178.0% of flowCOMMON STOCKSEC:0001213900-19-003242:1
- 160,000 shares@ US$21.0641COMMON STOCKSEC:0001213900-18-012296:0
- 4,800 shares@ US$20.5154COMMON STOCKSEC:0001213900-18-012296:1
- 200,000 shares@ US$20.9995COMMON STOCKSEC:0001213900-18-012091:0
- 11,468 shares@ US$21.0495COMMON STOCKSEC:0001213900-18-012091:1
- 40,000 shares@ US$20.6018COMMON STOCKSEC:0001213900-18-012091:2
- 14,026 shares@ US$18.521COMMON STOCKSEC:0001213900-18-011892:0
- 200,000 shares@ US$19.5914COMMON STOCKSEC:0001213900-18-011892:1
- 702 shares@ US$18.50COMMON STOCKSEC:0001213900-18-011094:0
- 10,602 shares@ US$18.60COMMON STOCKSEC:0001213900-18-010635:0
- 2,800 shares@ US$18.6066COMMON STOCKSEC:0001213900-18-010635:1
- 67,474 shares@ US$18.5076COMMON STOCKSEC:0001213900-18-010635:2
- 20,000 shares@ US$18.6611COMMON STOCKSEC:0001213900-18-009659:0
- 9,144 shares@ US$18.6288COMMON STOCKSEC:0001213900-18-009659:1
25 of 81 declarations
